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Objectives. The fibromyalgia syndrome (FMS) is a chronic condition with only few evidence-based complementary and alternative
therapies available. This paper presents a systematic review and meta-analysis of the effectiveness of Qigong for fibromyalgia
syndrome. Methods. The PubMed/MEDLINE, Cochrane Library, Embase, PsycINFO, and Cambase databases were screened in
December 2012 to identify randomized controlled trials comparing Qigong to control interventions. Major outcome measures
were pain and quality of life; and secondary outcomes included sleep quality, fatigue, depression, and safety. Standardized mean
differences (SMD) and 95% confidence intervals were calculated. Results. Seven trials were located with a total of 395 FMS patients.
Analyses revealed low quality evidence for short-term improvement of pain, quality of life, and sleep quality and very low quality
evidence for improvement of fatigue after Qigong for FMS, when compared to usual care. No evidence was found for superiority
of Qigong compared to active treatments. No serious adverse events were reported. Discussion. This systematic review found that
Qigong may be a useful approach for FMS patients. According to the quality of evidence, only a weak recommendation for Qigong
can be made at this point. Further high quality RCTs are required for the conclusive judgment of its long-term effects.
1. Introduction
The fibromyalgia syndrome (FMS) is a chronic condition
characterized by chronic widespread pain, fatigue, cognitive
disturbances, sleep disorders, and a high amount of somatic
and psychological distress [1, 2]. The prevalence of FMS in
the general population has been estimated between 2.9% and
3.8% in Europe [3, 4] with women being more frequently
affected than men [1]. Due to lack of data, only a few
complementary therapies can be recommended. One such
recommendation includes the application of meditative exer-
cise techniques such as yoga, Qigong, or tai chi [5]. The most
recent consumers report in Germany stated that 18.4% of
fibromyalgia patients currently used some kind of meditative
exercises, includingQigong [6]. Despite its recommendation,
no conclusive judgment on Qigong’s efficacy has been drawn
by reviews [7–9].
Qigong is a Chinese medical exercise that combines
static or dynamic physical exercises, breathing exercises,
and meditation [10]. Qigong aims to increase the energy
flow, the so-called qi, through the body [11]. Qigong is
well accepted in western societies; for example, in the US
estimated 500,000 individuals used Qigong for coping with
diseases such as musculoskeletal conditions, severe sprains,
and asthma [12], or even with cancer [13]. Qigong has proved
to be effective for physical conditions and for psychological
well-being [10], which could make it a valuable treatment
option for fibromyalgia patients, who suffer fromphysical and
psychological complaints.
Prior reviews have been conducted to test the efficacy of
Qigong for FMS [7–9]; however, no reliable conclusions could
be drawn due to the small number of included trials. The
aim of this systematic review and meta-analysis was to assess
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short- and long-term efficacy and safety of Qigong in patients
with FMS compared to control interventions.
2. Materials and Methods
2.1. Protocol and Registration. This review was planned
and conducted in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses guidelines
(PRISMA) [14], the recommendations of the Cochrane Mus-
culoskeletal Group [15, 16] Grading of Recommendations
Assessment, Development and Evaluation and the recom-
mendations (GRADE) [17]. The protocol was not registered
on any database.
2.2. Eligibility Criteria. To be eligible for review, studies were
required to meet the following conditions.
(1) Types of study designs: randomized controlled trials
(RCTs) were eligible.
(2) Types of participants: studies of patients with fibro-
myalgia were eligible, regardless of age, condition’s
duration, or intensity. No further restriction regard-
ing diagnostic procedures was applied.
(3) Types of interventions: studies that compared Qigong
with no treatment, usual care, or any active treatment
were eligible. No restrictions were applied to the
details of the Qigong. Cointerventions were allowed,
but studies with cointerventions were excluded in the
subsequent sensitivity analyses.
(4) Types of outcomes: studieswere eligible if they assessed
at least one major patient-centered outcome, namely,
pain or quality of life. Secondary outcomes were sleep
quality, fatigue, depression, and safety.
(5) Length of followup: no restrictions regarding length
of followup were applied. Short-term effects were
defined as measures taken directly after the interven-
tion and long-term effects as measures taken closest
to 12 months after randomization.
(6) Accessibility of data: studies were eligible only if they
were published as full papers. No language restriction
was applied.
2.3. Literature Search. The following electronic databases
were searched from their inception through to Decem-
ber 31, 2012: PubMed/MEDLINE, Embase, PsycINFO, the
Cochrane Library, and Cambase.The literature search, which
was constructed around search terms for “Qigong” and
“fibromyalgia syndrome,” was adapted for each database
as necessary. For example, the following search strategy
was used on the PubMed/MEDLINE database: (Fibromyal-
gia [MESH] OR fibromyalgia [Title/Abstract] OR fibrositis
[Title/Abstract] OR widespread pain [Title/Abstract]) AND
(Qigong [MESH] OR Qigong [Title/Abstract] OR Chi gong
[Title/Abstract] OR Chi kung [Title/Abstract] OR breathing
exercises [Title/Abstract]). The reference lists of identified
original articles or reviews were also searched manually for
relevant articles.
2.4. Study Selection. At first, all duplicate papers were
removed. Two reviewers then screened the abstracts of the
remaining papers individually. They went on to obtain the
full papers for all potentially eligible studies. The studies
were then checked for eligibility, with eligible papers being
included in the systematic review. Papers that provided data
on relevant clinical outcomes as defined in the next section
were also included in the meta-analysis.
2.5. Data Collection. Two reviewers independently extracted
data on studies’ characteristics (participants, interventions,
control conditions, cointerventions, outcome measures, and
results). Disagreements were discussed with a third reviewer
and resolved by agreement. If data could not be extracted
from the original published papers, their authors were con-
tacted.
2.5.1. OutcomeMeasures. To be eligible, studies had to at least
measure one major outcome, namely:
(1) pain intensity, measured on a visual analogue scale
(VAS), a numerical rating scale (NRS), the pain
subscale of the Fibromyalgia Impact Questionnaire
(FIQ) [18], or on another validated specific measure;
(2) disease specific health-related quality of life, assessed
by the Fibromyalgia Impact Questionnaire (FIQ) [18]
or any other validated instrument;
(3) generic health-related quality of life, assessed by the
World Health Organization Quality of Life Ques-
tionnaire (WHOL-QOL) [19], the Short Form 36
Health Survey Questionnaire (SF-36) [20], or on
another validated instrument eligible for patientswith
fibromyalgia. In case of multidimensional instru-
ments with several component summaries, only the
physical score was used for analyses.
Secondary outcomes included the following.
(1) Sleep quality was assessed on a visual analogue scale
(VAS), a numerical rating scale (NRS), the Pittsburgh
Sleep Quality Index (PSQI) [21], or on another val-
idated sleep quality index. If studies used multiple
instruments, the PSQI was preferred over the VAS.
(2) Fatigue was measured on a visual analogue scale
(VAS), a numerical rating scale (NRS), the Mul-
tidimensional Fatigue Inventory (MFI) [22], or on
another validated fatigue questionnaire. If studies
used multiple instruments, the MFI was preferred
over the VAS.
(3) Depression was included where this was measured
on the Beck Depression Inventory (BDI) [23] or
on another validated depression inventory. If studies
used multiple instruments, the BDI was preferred
over the others.
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(4) Patients’ safety was defined as any adverse event
occurring during a study.
2.5.2. Risk of Bias in Individual Studies. The risk of bias
at study level was assessed by two independent reviewers
using the 2006 Method guidelines for systematic reviews of
the Cochrane Musculoskeletal Group [16]. These guidelines
recommend the imposition of seven quality criteria, each
of which is rated as “low risk,” “high risk,” or “unclear
risk of bias.” These criteria relate to the following risk
of bias categories: random sequence generation (selection
bias), allocation concealment (selection bias), blinding of
participants and personnel (performance bias), blinding of
outcome assessors (detection bias), incomplete outcome data
(attrition bias), selective reporting (reporting bias), and other
bias relating to major study flaws.The risk of bias within each
domain was used to perform sensitivity analyses.
2.6. Data Analysis. Studies were analyzed separately for
their type of intervention (waitlist/usual care versus active
treatments) and for short- and long-term effects. Short-
term outcomes were defined as those from measures applied
directly after treatment and long-term outcomes from mea-
sures applied closest to the six months after randomization.
2.6.1. Assessment of Effect Size. If at least two studies pre-
sented data on an outcome, then meta-analysis was under-
taken using Review Manager 5 software (version 5.2, The
Nordic Cochrane Centre, Copenhagen, Denmark).
Standardized mean differences (SMD) with 95% confi-
dence intervals (CI) were calculated as the mean group dif-
ferences divided by the respective pooled standard deviations
[24]. Where no standard deviations were available, standard
errors, confidence intervals, or 𝑡 values were used to calculate
them. A random effect model was applied.
The magnitude of the overall effect size was classified
according toCohen’s categories: a small effect sizewas defined
as a SMD = 0.2 to 0.5, moderate effect size: SMD = 0.5 to 0.8,
and large effect size: SMD > 0.8 [25].
A negative standardized mean difference was defined to
indicate the beneficial effects of Qigong, as compared to the
control interventions, for all outcomes except generic quality
of life, where a positive SMD corresponded to enhanced well-
being. If necessary, patients’ scores were inverted and the
mean score was multiplied by −1.
2.6.2. Assessment of Heterogeneity. Statistical heterogeneity
between the reviewed studies was quantified by determina-
tion of 𝐼2. 𝐼2 > 30%, 𝐼2 > 50%, and 𝐼2 > 75% were
defined to indicate moderate, substantial, and considerable
heterogeneity, respectively [15]. A 𝑃 value ≤0.10 from the 𝜒2
test was taken to indicate significant heterogeneity [15].
2.6.3. Subgroup and Sensitivity Analyses. Subgroup analyses
were conducted for studies that applied Qigong as part of a
comprehensive program versus studies that used Qigong as a
standalone treatment.
Sensitivity analyses to test the robustness of any signif-
icant results were conducted by comparing the results of
studies with high risk versus low risk at the domains selection
bias, detection bias, attrition bias, and other risks. If statistical
heterogeneity was present in the respective meta-analysis,
sensitivity analyses were conducted by subsequent exclusion
of single studies.
2.6.4. Risk of Bias across Studies. If at least ten studies were
included in a meta-analysis, the risk of publication bias
was assessed by visual analysis of funnel plots generated by
Review Manager 5.1 software. Roughly symmetrical funnel
plots indicate a low risk of publication bias, while asymmet-
rical funnel plots indicate a high risk of such bias [26].
2.6.5. Quality of Evidence. The quality of evidence for each
outcome was judged according to the GRADE recommen-
dations [17] based on the methodological quality and the
confidence in the results of the meta-analysis.
(1) High quality: further research is very unlikely to
change the confidence in the estimate of effect.
(2) Moderate quality: further research is likely to have an
important impact on the confidence in the estimate of
effect and may change the estimate.
(3) Low quality: further research is very likely to have an
important impact on our confidence in the estimate
of effect and is likely to change the estimate.
(4) Very low quality: any estimate of effect is very uncer-
tain.
2.6.6. Strength of Recommendation. The strength of recom-
mendation for Qigong as a therapeutic option is judged
according to GRADEwith either “strong” or “weak” [17].This
recommendation takes into account the quality of evidence
and the risk of undesirable effects.
3. Results
3.1. Study Selection. The literature search retrieved 147
records, of which 26 were duplicates (Figure 1). After abstract
screening, 103 records were excluded. Of the remaining 13
articles that were assessed as full text, 6 either referred to
studies that did not investigate Qigong (𝑁 = 5) [27–31] or
that were not randomized (𝑁 = 1) [32]. At the end, 7 studies
with a total of 395 patients could be included in the qualitative
and quantitative analysis [33–39].
3.2. Study Characteristics. The characteristics of the study
samples, interventions, outcome measures, and results are
shown in Table 1.
3.2.1. Setting and Participant Characteristics. Trials origi-
nated fromAustralia [38], Canada [36], Sweden [34, 39], Italy
[37], and USA [33, 35]. All except for one study included
patients who had been diagnosed according to the American
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Figure 1: Flow chart of results of the literature search.
College of Rheumatology (ACR) diagnostic criteria [33, 35–
39], and one study did not refer to the diagnostic procedure
[34]. Four studies included adults of both genders [33, 35–
37], whereas three studies included only females [34, 39]
or children [38]. All studies were conducted in primary or
secondary care settings.
3.2.2. Intervention Characteristics. Qigong was practiced
between 6 and 12 weeks with one or two supervised sessions
a week and additional home practices up to two sessions a
week. In one study [36] patients practiced Qigong at home
until the 6-month followup.
The studies’ control interventions differed widely. Three
studies used a wait-list or usual care group [34, 36, 39],
one study included a sham Qigong [35], one study used an
education and support group [33], one study used a body
awareness training (Resse´guier method) [37], and another
one aerobic exercises [38].
3.2.3. Outcome Measures. Pain was assessed as an outcome
measure in all studies, with three studies using the NRS
[34, 36, 37] and one using VAS [38], the pain scale of the
FIQ [39], amyalgic score based on the tender point sensitivity
[33], or the Short-Form McGill Pain Questionnaire (SMPQ)
[35]. Disease specific quality of life was measured in five
studies using the FIQ [33, 35–37, 39] and in one study using
the Childhood Health Assessment Questionnaire (C-HAQ)
[38]. Generic quality of life was assessed in four studies by
means of the WHO-QOL [34], the SF-36 [36, 37], or the
Quality of My Life Scale (QOML) [38].
Sleep quality was assessed in four studies [34–37] with
two studies using the PSQI [35, 36] and two studies using
a NRS [34, 37]. Fatigue was measured in one study using a
NRS [34], the MFI [35], the fatigue scale of the FIQ [39], or
the fatigue module of the Pediatric Quality of life Inventory
(PedsQL) [38]. Depressionwasmeasured in two studies using
the BDI [33, 34], in one study using the subscale of the
FIQ [39], the subscale depression of the Hamilton Anxiety
and Depression Scale (HADS) [37], and the Childhood
Depression Inventory (CDI) [38]. Safety was assessed and
reported in two trials [36, 38].
Short-term effects were assessed in all studies, but only
two studies investigated long-term effects [33, 39]. The study
of Maddali Bongi et al. [37] investigated long-term effect;
however, due to the cross-over character of the study the
follow-up data could not be used.
3.2.4. Risk of Bias in Individual Studies. No study was
considered to be serious flawed (see Table 2). Studies’ risk
of selection bias was mixed, with four out of seven studies
having low risk at random sequence generation [33, 36–
38] and only three studies having low risk at allocation
concealment [33, 37, 38]. All other studies have unclear risk
of selection bias since they did not describe the procedures in
detail.
The risk of performance bias was mostly unclear and one
study had high risk of bias in that domain [35]. Detection bias
was low in all studies. Attrition bias was mixed with three out
Evidence-Based Complementary and Alternative Medicine 7
















(selection bias) (selection bias) (performance bias) (detection bias) (attrition bias) (reporting bias)
Astin et al., 2003 [33] + + ? + − + +
Haak and Scott, 2008
[34] ? ? ? + + − +
Liu et al., 2012 [35] ? ? − + + + +
Lynch et al., 2012 [36] + ? ? + + + +
Maddali Bongi et al.,
2012 [37] + + ? + + + +
Mannerkorpi and
Arndorw, 2004 [39] ? ? ? + − + +
Stephens et al., 2008
[38] + + ? + − + +
“+” means low risk, “−” means high risk, and “?” means unclear risk of bias.
of seven studies having a high risk of bias, mainly because of
high drop-out rates or nondescribing reasons for withdrawals
[33, 38, 39]. Reporting bias was only high risk in one study
[34].
3.3. Qigong versus Waitlist/Usual Care
3.3.1. Analyses of Effects of Qigong versus Waitlist/Usual Care
Major Outcomes
(1) Pain: evidence was found for a moderate short-term
effect of Qigong on pain intensity (SMD = −0.69;
95% CI −1.25 to −0.12; 𝑃 < 0.02; heterogeneity: 𝐼2 =
63%; 𝜒2 = 5.43; 𝑃 = 0.07) (Figure 2). Long-term
effects could not be assessed because there was only
one study [36], which showed a moderate effect on
pain intensity (SMD = −0.51; 95% CI −0.93 to −0.08;
𝑃 = 0.02).
(2) Disease specific quality of life: no short-term effects
were found for disease-specific quality of life (SMD =
−0.54; 95% CI −1.78 to 0.70; 𝑃 = 0.39) (Figure 2).
Long-term effects could not be calculated; however,
results of the only study [36] with that outcome
indicated a strong effect (SMD = −1.10; 95% CI −1.55
to −0.65; 𝑃 < 0.001).
(3) Generic quality of life: a strong short-term effect was
found for generic quality of life (SMD = 0.84; 95%
CI 0.49 to 1.18; 𝑃 < 0.001; heterogeneity: 𝐼2 = 0%;
𝜒
2
= 0.30; 𝑃 = 0.58) (Figure 2). Only one study [36]
investigated the long-term effects on generic quality
of life with a moderate effect (SMD = 0.64; 95% CI
0.21 to 1.07; 𝑃 = 0.003).
Secondary Outcomes
(1) Sleep quality: a moderate short-term effect of Qigong
on sleep quality was found (SMD = −0.67; 95% CI
−1.01 to −0.34; 𝑃 < 0.001; heterogeneity: 𝐼2 =
0%; 𝜒2 = 0.37; 𝑃 = 0.54) (Figure 3). For long-
term comparison, only data from one study [36]
were available indicating a moderate long-term effect
(SMD = −0.66; 95% CI −1.09 to −0.23; 𝑃 = 0.003).
(2) Fatigue: evidence was found for a moderate short-
term effect on fatigue (SMD = −0.56; 95% CI −1.07 to
−0.06; 𝑃 = 0.03; heterogeneity: 𝐼2 = 12%; 𝜒2 = 1.14;
𝑃 = 0.29) (Figure 3). No data were available for long-
term comparisons.
(3) Depression: no effect could be calculated for short-
term influences on depression. The only study avail-
able [34] indicated a significant effect on depression
(SMD = −0.54; 95% CI −1.07 to −0.00; 𝑃 < 0.05)
(Figure 3). No data were available for long-term
comparisons.
3.3.2. Subgroup and Sensitivity Analyses of Qigong versus
Waitlist/Usual Care. A subgroup analysis showed that, after
exclusion, the study that used Qigong as part of a com-
prehensive program [39] and the significant effect on pain
intensity remained in those who used Qigong as standalone
treatment [34, 36]. For disease-specific quality of life, there
was only one study left after exclusion [36]; therefore, it
was not possible to draw reliable conclusions. For the other
outcomes, no subgroup analyses were possible, because the
study by Mannerkorpi and Arndorw [39] did not assess any
other outcomes.
No sensitivity analyses could be conducted for low versus
high risk of selection bias, since no study had high risk, and
the same was true for detection bias and other bias. Analyses
regarding attrition bias showed no changes on pain, generic
quality of life, sleep quality, and depression after exclusion of
the high risk study [39]. After exclusion only one study was
left on fatigue, still with a significant effect (SMD=−0.74; 95%
CI −1.28 to −0.19; 𝑃 = 0.008).
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(2) Disease-specific quality of life
2.1 Qigong versus usual care
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Figure 2: Forrest plots for major short-term outcomes.
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Figure 3: Forrest plots for secondary short-term outcomes.
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Sensitivity analyses for determination of causes for het-
erogeneity also revealed that the study by Mannerkorpi and
Arndorw [39] was the main contributor for heterogeneity.
Since that study was excluded in prior sensitivity analyses, no
further analyses seemed necessary.
3.3.3. Quality of Evidence. The quality of evidence according
to GRADE was judged low for pain, quality of life, and
sleep quality. Since only RCTs were included, the quality
of evidence started at high quality, and then downgraded
because of serious issues regarding risk of bias (−1) and
imprecision due to small sample size (−1). For fatigue,
the quality of evidence was judged very low after another
downgradingwas done because of inconsistency of the results
(−1).
3.4. Qigong versus Active Treatment
3.4.1. Analyses of Effects of Qigong versus Active Treatment
Major Outcomes
(1) Pain: no effects were found for short- (SMD = −0.22;
95% CI −1.04 to 0.60; 𝑃 = 0.60) or long-term effects
(SMD = −0.04; 95% CI −0.58 to 0.49; 𝑃 = 0.87)
of Qigong compared to active treatments on pain
intensity (Figure 2).
(2) Disease specific quality of life: no effect was found
for disease-specific quality of life on the short-term
(SMD = −0.23; 95% CI −1.06 to 0.60; 𝑃 = 0.59)
(Figure 2). No long-term effects could be assessed;
the only available study [33] indicated no significant
effect (SMD = −0.19; 95% CI −0.68 to 0.30; 𝑃 =
0.45).
(3) Generic quality of life: no effect was found for
the short-term comparison of Qigong versus active
treatment (SMD = −0.32; 95% CI −0.86 to 0.22;
𝑃 = 0.24) (Figure 2). No study assessed long-term
effects.
Secondary Outcomes
(1) Sleep quality: no effect of Qigong was found for
sleep quality on the short-term (SMD = −0.03; 95%
CI −1.64 to 1.58; 𝑃 = 0.97) (Figure 3). Long-
term comparisons were not possible due to lack of
data.
(2) Fatigue: no effect of Qigong was found for fatigue on
the short-term (SMD = −0.36; 95% CI −2.36 to 1.63;
𝑃 = 0.72) (Figure 3). Long-term comparisons were
not possible due to lack of data.
(3) Depression: no effect was found for depression on
the short-term (SMD = −0.40; 95% CI −1.07 to 0.27;
𝑃 = 0.24) (Figure 3). No long-term effects could be
assessed; the only available study [33] indicated no
significant effect (SMD= −0.20; 95%CI −0.69 to 0.29;
𝑃 = 0.43).
3.4.2. Sensitivity Analyses of Qigong versus Active Treatment.
No sensitivity analyses were conducted due to the absence of
any significant effect.
3.5. Safety. Only three studies [36–38] reported adverse
events. Two studies stated that no adverse events occurred
[37, 38], and the third study [36] found two adverse events,
namely, shoulder pain and plantar fasciitis; both events were
transitory and fully resolved over time.
3.6. Risk of Bias across Studies. As less than ten studies
were included in each meta-analysis, funnel plots were not
analyzed.
3.7. Strength of Recommendation. Despite the fact that
Qigong was not associated with serious adverse events, only
weak recommendations could be made, mainly due to the
small number of studies and low quality of evidence.
4. Discussion
4.1. Summary of Main Results. This meta-analysis found low
quality evidence for moderate-to-strong effects of Qigong on
pain, quality of life, and sleep quality and very low quality
evidence for moderate effects on fatigue, when compared to
usual care control groups. No effects were found for disease-
specific quality of life and no effects could be calculated for
depression or any long-term outcome. This meta-analysis
also found no evidence for effects of Qigong on any outcome
when compared to active control groups.
Data on safety were reported only in three studies with no
occurrence of serious adverse events.
4.2. Applicability of Evidence. The reviewed trials were con-
ducted in primary and secondary care settings in different
countries. Most patients were adults in their 50s (except for
30 children [38]) and female; some studies did not state the
numbers of male and female patients. All but one study [34]
included patients with a diagnosis according to the ACR
1990 classification [40]. Cointerventions were mentioned in
three studies [34, 35, 39] only and they consisted primarily of
medication. Knowing that fibromyalgia patients are mainly
female [1] and treated in primary and secondary care [6], this
review’s results potentially apply to the majority patients with
fibromyalgia.
4.3. Quality of Evidence. Whilst the methodological quality
of the studies reviewed differed somewhat, the effects of
Qigong compared to usual care were robust against method-
ological bias. After excluding high risk studies, these effects
remained for the most part. According to the GRADE
recommendations, the quality of evidence ranged from low
(for pain, quality of life, and sleep quality) to very low (for
fatigue).
4.4. Agreements and Disagreements with Other Systematic
Reviews. A thorough literature search located three other
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reviews of Qigong for fibromyalgia [7–9]; however, in one
of them it was part of a larger review on exercise [9] or
meditative movement therapies [7]. While the first review
[9] included only two studies on Qigong for fibromyalgia,
Langhorst et al. [7] assessed three studies in a meta-analysis
[34, 38, 39] and concluded that they found no evidence to
support its efficacy. The most recent review [8] reported
on four RCTs, but did not conduct a meta-analysis and
concluded that it was too early to judge the efficacy of Qigong
for fibromyalgia.
Given the seven RCTs included in this review and the
evidence found for effects of Qigong compared to usual care
but not to active controls, the review suggests that Qigong
might be effective on the short term. The effect sizes are
also mostly comparable to those of aerobic exercise [41].
Unfortunately this review and meta-analysis does not allow
for conclusions regarding the long-term efficacy.
4.5. Strengths andWeaknesses. This review andmeta-analysis
study was conducted in accordance with the recommenda-
tions with the Cochrane Musculoskeletal Group [16] and for
the first time reliable conclusions on the efficacy of Qigong
could be drawn.
The review’s primary limitation is the paucity of eligible
trials, which rendered further subgroup analyses impossible.
Studies especially comparing Qigong to other active thera-
pies and studies investigating long-term effects are urgently
needed.
Another limitation is the fact that in some studies Qigong
was part of more comprehensive treatment program such as
mindfulness meditation [33] or body awareness therapy [39],
which makes it almost impossible to determine the isolated
effect of Qigong.
Limiting factors are not only based on the studies design
but also on the reporting of the conduction and the results.
Most studies did not report randomization, allocation con-
cealment, or blinding sufficiently. Some of the studies also
used statistical within group comparisons but not between
group comparisons despite the randomized controlled study
design. Future studies should address these critical issues.
Heterogeneity was present in some meta-analyses; how-
ever, due to the small number of studies heterogeneity could
not always be determined in sensitivity analyses.
4.6. Strength of Recommendation. According to GRADE,
only a weak recommendation for Qigong can be made at this
point.
5. Conclusion
This systematic review found low quality evidence for a
short-term improvement of pain, quality of life, sleep quality,
and very low quality evidence for improvement of fatigue
after Qigong for fibromyalgia, when compared to usual care
intervention. Given the low number of reported adverse
events, Qigong may be a useful and safe approach in treating
fibromyalgia. No evidence was found for Qigong compared
to other active treatments. Further high quality RCTs that
compare Qigong to established therapies (e.g., defined drug
treatment, aerobic exercise) that report responder rates (e.g.,
−30% pain reduction) and that systematically assess adverse
events are required for the conclusive judgment of its long-
term effects.
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